PURPOSE: Screening for fecal occult blood reduces colorectal cancer mortality by identifying patients with positive results for complete diagnostic evaluation (CDE). CDE rates are suboptimal, however. We sought to determine common reasons for nonperformance of a CDE as recorded by the primary care physician. METHODS: We undertook a descriptive analysis of reasons reported by physicians for nonperformance of CDE in a nested sample of patients with positive fecal occult blood test (FOBT) results from a randomized controlled trial designed to evaluate the impact of a physician intervention (CDE reminder-feedback and educational outreach) on recommendation and performance rates in primary care practices. Inspection of administrative data for 1,468 patients with positive results showed that 661 (45%) did not undergo CDE. We reviewed patient follow-up forms, which were completed by physicians for patients who did not have a CDE, to identify reasons for nonperformance. RESULTS:Nonperformance of CDE was due to physician decision for 217 patients (33%). In 123 patients (19%), reasons for nonperformance were compatible with the guidelines, and in 94 patients (14%), they were not. Reasons wholly or partially due to factors other than physician decision were noted in 212 patients (32%); physician action was considered to be appropriate in these patients. For the 232 patients (35%) without a clearly documented reason for CDE nonperformance, the appropriateness of the physicians' action could not be determined. CONCLUSIONS: Decision making by primary care physicians had a major effect on nonperformance of CDE after a positive FOBT result. Colorectal cancer screening programs should include guidance for physicians about when a CDE should and should not be performed.
RCT Entities:
PURPOSE: Screening for fecal occult blood reduces colorectal cancer mortality by identifying patients with positive results for complete diagnostic evaluation (CDE). CDE rates are suboptimal, however. We sought to determine common reasons for nonperformance of a CDE as recorded by the primary care physician. METHODS: We undertook a descriptive analysis of reasons reported by physicians for nonperformance of CDE in a nested sample of patients with positive fecal occult blood test (FOBT) results from a randomized controlled trial designed to evaluate the impact of a physician intervention (CDE reminder-feedback and educational outreach) on recommendation and performance rates in primary care practices. Inspection of administrative data for 1,468 patients with positive results showed that 661 (45%) did not undergo CDE. We reviewed patient follow-up forms, which were completed by physicians for patients who did not have a CDE, to identify reasons for nonperformance. RESULTS: Nonperformance of CDE was due to physician decision for 217 patients (33%). In 123 patients (19%), reasons for nonperformance were compatible with the guidelines, and in 94 patients (14%), they were not. Reasons wholly or partially due to factors other than physician decision were noted in 212 patients (32%); physician action was considered to be appropriate in these patients. For the 232 patients (35%) without a clearly documented reason for CDE nonperformance, the appropriateness of the physicians' action could not be determined. CONCLUSIONS: Decision making by primary care physicians had a major effect on nonperformance of CDE after a positive FOBT result. Colorectal cancer screening programs should include guidance for physicians about when a CDE should and should not be performed.
Authors: R E Myers; B Turner; D Weinberg; W W Hauck; T Hyslop; T Brigham; T Rothermel; J Grana; N Schlackman Journal: Prev Med Date: 2001-10 Impact factor: 4.018
Authors: Nadeem Baig; Ronald E Myers; Barbara J Turner; James Grana; Todd Rothermel; Neil Schlackman; David S Weinberg Journal: Am J Gastroenterol Date: 2003-09 Impact factor: 10.864
Authors: Sidney Winawer; Robert Fletcher; Douglas Rex; John Bond; Randall Burt; Joseph Ferrucci; Theodore Ganiats; Theodore Levin; Steven Woolf; David Johnson; Lynne Kirk; Scott Litin; Clifford Simmang Journal: Gastroenterology Date: 2003-02 Impact factor: 22.682
Authors: Ronald E Myers; Barbara Turner; David Weinberg; Terry Hyslop; Walter W Hauck; Timothy Brigham; Todd Rothermel; James Grana; Neil Schlackman Journal: Prev Med Date: 2004-04 Impact factor: 4.018
Authors: Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer Journal: CA Cancer J Clin Date: 2008-03-05 Impact factor: 508.702
Authors: Usha Menon; Rhonda Belue; Stéphanie Wahab; Kathryn Rugen; Anita Y Kinney; Peter Maramaldi; Debra Wujcik; Laura A Szalacha Journal: Ann Behav Med Date: 2011-12
Authors: Adrian H Zai; Seokjin Kim; Arnold Kamis; Ken Hung; Jeremiah G Ronquillo; Henry C Chueh; Steven J Atlas Journal: J Am Med Inform Assoc Date: 2013-09-16 Impact factor: 4.497
Authors: Marion R Nadel; Zahava Berkowitz; Carrie N Klabunde; Robert A Smith; Steven S Coughlin; Mary C White Journal: J Gen Intern Med Date: 2010-04-10 Impact factor: 5.128
Authors: Hardeep Singh; Lindsey Wilson; Laura A Petersen; Mona K Sawhney; Brian Reis; Donna Espadas; Dean F Sittig Journal: BMC Med Inform Decis Mak Date: 2009-12-09 Impact factor: 2.796